Trades on 2 secondary markets

IAMBIC

Iambic Therapeutics is a clinical-stage AI drug discovery company headquartered in San Diego. Its proprietary AI platform pairs the NeuralPLexer 3D generative model for protein-ligand structure prediction with the Enchant multimodal transformer for clinical and preclinical endpoint prediction, integ

minimal 10.9 / 100 0 APIs View provider profile →
Drug DiscoveryAI for ScienceTherapeuticsBiotechOncologyClinical-Stage Pipeline

IAMBIC is an API provider whose private shares are listed on 2 secondary markets: Hiive, Nasdaq Private Market.

Where It Trades

H Hiive View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.